{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:26Z","timestamp":1793394986439,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.xphs.2024.02.019","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T10:57:53Z","timestamp":1708685873000},"page":"1919-1926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8962-2559","authenticated-orcid":false,"given":"Shailendra","family":"Jadiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Upmanyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-5341","authenticated-orcid":false,"given":"Arulmozhi","family":"Sathiyanarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupal","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Buwade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2024.02.019_bib0001","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jgh3.12706","article-title":"Immune-mediated inflammatory diseases of the gastrointestinal tract: beyond Crohn's disease and ulcerative colitis","volume":"6","author":"Vuyyuru","year":"2022","journal-title":"JGH Open"},{"key":"10.1016\/j.xphs.2024.02.019_bib0002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2478\/jim-2021-0031","article-title":"Etiopathogenic and clinical aspects in inflammatory bowel disease\u2013literature review","volume":"6","author":"Isac","year":"2021","journal-title":"J Interdiscip Med"},{"key":"10.1016\/j.xphs.2024.02.019_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12178-011-9085-8","article-title":"Inflammatory bowel disease associated arthropathy","volume":"4","author":"Arvikar","year":"2011","journal-title":"Curr Rev Musculoskeletal Med"},{"key":"10.1016\/j.xphs.2024.02.019_bib0004","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11894-008-0108-6","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"10","author":"Williams","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.xphs.2024.02.019_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","volume":"12","author":"Seyedian","year":"2019","journal-title":"J Med Life"},{"key":"10.1016\/j.xphs.2024.02.019_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1208\/s12249-023-02512-z","article-title":"Twin screw melt granulation: alternative approach for improving solubility and permeability of a non-steroidal anti-inflammatory drug ibuprofen","volume":"24","author":"Nyavanandi","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2024.02.019_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/17474124.2019.1574569","article-title":"Extraintestinal manifestations in inflammatory bowel disease\u2013epidemiology, genetics, and pathogenesis","volume":"13","author":"Greuter","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.xphs.2024.02.019_bib0008","first-page":"1273","article-title":"J. Revisiting inflammatory bowel disease: pathology, treatments, challenges and emerging therapeutics including drug leads from natural products","volume":"9","author":"Yeshi","year":"2020","journal-title":"Clin Med"},{"key":"10.1016\/j.xphs.2024.02.019_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.111465","article-title":"D. Sulfasalazine-loaded nanoparticles for efficient inflammatory bowel disease therapy via ROS-scavenging strategy Jiang","volume":"225","author":"Lin","year":"2023","journal-title":"Mater Des"},{"key":"10.1016\/j.xphs.2024.02.019_bib0010","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","article-title":"Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee","volume":"99","author":"Kornbluth","year":"2004","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"10.1016\/j.xphs.2024.02.019_bib0011","first-page":"e493","article-title":"A.A.C.E. Sulfasalazine-induced hypoglycemia in a patient with type 2 diabetes and end-stage renal disease","volume":"4","author":"Stamatiades","year":"2018","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.xphs.2024.02.019_bib0012","first-page":"1","article-title":"Managing inflammatory bowel disease in adolescent patients","volume":"5","author":"Bishop","year":"2014","journal-title":"Adolesc Health Med Ther"},{"key":"10.1016\/j.xphs.2024.02.019_bib0013","first-page":"1","article-title":"Formulation design, characterisation and in vitro evaluation of bilayered tablets containing Telmisartan and Hydrochlorthizide Int","volume":"4","author":"Noor","year":"2013","journal-title":"J Biopharm"},{"key":"10.1016\/j.xphs.2024.02.019_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122283","article-title":"Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet","volume":"628","author":"Nyavanandi","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2024.02.019_bib0015","first-page":"728","article-title":"Design, development and optimizations of fast dissolving tablet of Ondansetron HCl using mannitol with camphor, subliming material Int","volume":"5","author":"Bhatt","year":"2013","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.xphs.2024.02.019_bib0016","first-page":"516","article-title":"Formulation and development of bilayer tablet containing telmisartan and indapamide","volume":"2","author":"Patidar","year":"2012","journal-title":"IJDDHR"},{"key":"10.1016\/j.xphs.2024.02.019_bib0017","first-page":"388","article-title":"Formulation, in vitro and in vivo evaluation of pioglitazone hydrochloride - Effervescent gastro retentive floating hydrophilic matrix tablets","volume":"9","author":"Thulluru","year":"2016","journal-title":"Int J PharmTech Res"},{"key":"10.1016\/j.xphs.2024.02.019_bib0018","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1208\/s12248-012-9422-x","article-title":"A novel beads-based dissolution method for the in-vitro evaluation of extended release HPMC matrix tablets and the correlation with the in-vivo data","volume":"15","author":"Klan\u010dar","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2024.02.019_bib0019","unstructured":"ICH Harmonised Tripartite Guideline. Stability Testing of New Drug Substances and Products Q1A(R2). http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q1A_R2\/Step4\/Q1A_R2__Guideline.pdf Accessed 23 July 2017"},{"key":"10.1016\/j.xphs.2024.02.019_bib0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jddst.2018.01.008","article-title":"Formulation and Optimization of enteric coated bilayer tablets of mesalamine by RSM: in vitro - in vivo investigation and roentogenographic study","volume":"44","author":"Parmar","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2024.02.019_bib0021","first-page":"19","article-title":"Spherical crystallisation: a revolution in the field of particle engineering","volume":"7","author":"Keshwani","year":"2015","journal-title":"Int J Curr Pharm Res"},{"key":"10.1016\/j.xphs.2024.02.019_bib0022","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.xphs.2015.12.019","article-title":"Review of disintegrants and the disintegration phenomena","volume":"105","author":"Desai","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.02.019_bib0023","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.apt.2019.11.031","article-title":"Powder flow and mixing in different tablet press feed frames","volume":"31","author":"Siegmann","year":"2020","journal-title":"Adv Powder Technol"},{"key":"10.1016\/j.xphs.2024.02.019_bib0024","first-page":"72","article-title":"Studies on development of sustained release diltiazem hydrochloride matrices through jackfruit mucilage","volume":"6","author":"Shende","year":"2014","journal-title":"Int J Pharm Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T08:34:36Z","timestamp":1718181276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0022354924000625"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.02.019","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}